Biopharmaceutics and pharmacokinetics of plain and soluble brands of aspirin tablets embedded in food bolus orally administered to human volunteers

Authors

  • Emmanuel Adelaja Bamigbola Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria. https://orcid.org/0000-0002-0686-8906
  • Jude Nkemjika Oraeluno Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.
  • Amaka Victoria Ekezie Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

Abstract

Many people ingest solid drugs embedded in food bolus to alleviate the problems of gastric irritation, unpleasant taste and odour which may affect the biopharmaceutics and pharmacokinetics of the drugs. This study investigated the biopharmaceutics and pharmacokinetics of plain and soluble brands of aspirin tablets embedded in food bolus orally administered to human volunteers. The pharmacokinetic profiles of two brands of commercial, uncoated aspirin tablets (300 mg) were assessed in eight healthy human volunteers when taken unembedded and when embedded in food bolus. The tablet samples were coded as S (soluble or dispersible aspirin tablet), P (plain or immediate-release aspirin tablet), SB (soluble aspirin tablet embedded in food bolus) and PB (plain aspirin tablet embedded in food bolus). Pharmacokinetic parameters generated from the salivary excretion data were evaluated. The biopharmaceutics factors of the drugs were also considered. The cumulative drug excreted up to 24 hours [E24h]  and maximum excretion rate [dE/dt]max of S were significantly higher (P < 0.05) than P, SB and PB. Time for maximum excretion rate [Tmax] of S was significantly lower (P < 0.05) than P, SB and PB. There was no significant difference (P > 0.05) between P and SB, but PB had significantly lower E24h, and [dE/dt]max (P < 0.05) and significantly higher Tmax (P < 0.05) than P and SB. Food coating and excipients were observed as the biopharmaceutics factors that influenced the pharmacokinetics of the aspirin tablets. Biopharmaceutics and pharmacokinetics of aspirin tablets may be significantly altered when embedded in food bolus.

Keywords:  Biopharmaceutics; Pharmacokinetics; Bioavailability; Food Bolus; Aspirin.

Keywords:

Biopharmaceutics, Pharmacokinetics, Bioavailability, Food Bolus, Aspirin

DOI

https://doi.org/10.22270/jddt.v16i7.7906

Author Biographies

Emmanuel Adelaja Bamigbola , Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Federal University Oye-Ekiti, 371104, Ekiti State, Nigeria.

Jude Nkemjika Oraeluno , Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

Amaka Victoria Ekezie , Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Niger Delta University, 560103, Wilberforce Island, Bayelsa State, Nigeria.

References

1. Lou J, Duan H, Qin Q, Teng Z, Gan F, Zhou X, Zhou X. Advances in oral drug delivery systems: Challenges and opportunities. Pharmaceutics, 2023; 15(2):484. https://doi.org/10.3390/pharmaceutics 15020484

2. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021; 12:618411. https://doi.org/10.3389/fphar.2021.618411

3. Rubbens, J., Veiga, R., Brouwers, J., and Augustijns, P. (2018). Exploring gastric drug absorption in fasted and fed state rats. Int J Pharmaceut.2018; 548 (1): 636–641. https://doi.org/10.1016/j.ijpharm. 2018. 07.017

4. Syed FA, Fouzia H, Baqars N, Syed, MFH. Studies of food drug interactions. Pak J Pharm Sci. 2010; 23(3).313-320

5. Caliph SM, Charman WN, Porter CJ. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000; 89(8): 1073-84. https://doi.org/10.1002/1520-.6017(200008)89:8<1073:aidjps12>3.0.co;2-v

6. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res. 2005; 22(1):11-23. https://doi.org/10.1007/s11095-004-9004-4

7. Bamigbola E A, Orubu ESF, Ogoro ES. Disintegration and Dissolution Studies of Plain and Soluble Brands of Aspirin Tablets Embedded in Food Bolus. Nig J Pharm Res. 2018; 14 (1): 43-52.

8. Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985; 10 (2):164-177. https://doi.org/10.2165/00003088-198510020-00004

9. Adelaja E. Correlation of in vitro Dissolution Profiles with in vivo Pharmacokinetic Parameters of Some Commercial Brands of Aspirin Tablets Marketed in Nigeria. In: Noreddin A, editor. Readings in Advanced Pharmacokinetics - Theory, Methods and Applications. 1st ed. Croatia: Intech publisher; 2012. p. 251-266. http://doi.org/10. 5772/33621

10. Kanani K, Sergio C. Gatoulis SC, Voelker M. Influence of differing Analgesic Formulations of Aspirin on Pharmacokinetic Parameters. Pharmaceutics. 2015; 7:188-198. https://doi.org/:10.3390/ pharmaceutics7030188

11. Levy G, Procknal JA, Olufs R, Pachman LM. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis. Clin Pharmacol Ther. 1980; 27(5):619-627. https://doi.org/10.1038/clpt.1980.88

12. Shargel L and Yu ABC. Introduction to biopharmaceutics and pharmacokinetics. In: Shargel L, Yu ABC, editors. Applied biopharmaceutics and pharmacokinetics. 6th ed. New York: McGraw-Hill; 2016. p. 1-4.

13. Prabu SL, Suriyaprakash TNK, Ruckmani K, Thirumurugan R. Biopharmaceutics and pharmacokinetics. In: Ahmed TA, editor. Basic pharmacokinetic concepts and some clinical applications. 4th ed. UK: IntechOpen Limited; 2015. https://doi.org/:10.5772/61160

14. Talevi A, Quiroga, PAM. Introduction. Biopharmaceutics and pharmacokinetics. In: Talevi A, Quiroga P. editors. ADME processes in pharmaceutical sciences. Springer, Cham; 2018; https://doi.org/10.1007/978-3-319-99593-9_1

15. Anup N, Rajpoot K, Tekade RK. Overview of biopharmaceutics and pharmacokinetics. In: Tekade RK editor. Advances in pharmaceutical product development and research, biopharmaceutics and pharmacokinetics considerations. Academic Press. 2021; 1. 1-16. https://doi.org/10.1016/B978-0-12-814425-1.00023-1.

16. Samineni R, Chimakurthy J, Konidala S. Emerging role of biopharmaceutical classification and biopharmaceutical drug disposition system in dosage form development: A systematic review. Turk J Pharm Sci. 2022; 19(6):706-713. https://doi.org/:10.4274/tjps.galenos.2021.73554

17. Yasir M, Asif M, Kumar A. Biopharmaceutical classification system: An account. Int J Pharm Tech Res. 2010; 2(3), 1683.

18. Bamigbola EA, Ibrahim MA, Attama AA, Arute, J.E. Comparative bioequivalence assessment of aspirin tablets marketed in Nigeria. Int J Health Res. 2009; 2 (4):375-379 https://doi.org/:10.4314/ijhr.v2i4554 39

19. Saikh MMA. Aqueous film coating the current trend. J Drug Deliv Ther 2021; 11:212-24. https://doi.org/:22270/jddt.v11i4-S.4911

20. Abrahamson B, Albery T, Eriksson A, Gustafsson I, Sjoberg M. Food effects on tablet disintegration. Eur J Pharm Sci. 2004; 2-3: 165-172.

21. Yasuji T, Kondo H, Sako K. The effect of food on the oral bioavailability of drugs: a review of current developments and pharmaceutical technologies for pharmacokinetic control. Ther Deliv. 2011 3 (1). https://doi.org/10.4155 /tde.11.142

22. Bravo SA, Lamas MC Salomon CJ. Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies. Pharm Dev Tech. 2004; 9 (1) 75-83. https://doi.org/10.1081/PDT-120027420

23. Kiran KS, Rao RT, Jayaveera KN. Matrix tablets as controlled drug delivery systems. Ind Amer J Pharm Res. 2011; 1 (4): 343-350. https://doi.org/10.5281/zenedo.2295200

24. Chaubai MV. Polyanhydrides: Applications in sustained release and bioadhesive dosage forms. Drug Dev Deliv. 2004; 4 (3):11-12

Li J, Mooney DJ. Designing hydrogels for controlled drug delivery. Nat Rev Mater. 2016; 1 (12) 160-71. https://doi.org/10.1038/natrevmats.2016.71

Published

2026-07-15
Statistics
Abstract Display: 0
PDF Downloads: 0
PDF Downloads: 0

How to Cite

1.
Bamigbola EA, Oraeluno JN, Ekezie AV. Biopharmaceutics and pharmacokinetics of plain and soluble brands of aspirin tablets embedded in food bolus orally administered to human volunteers. J. Drug Delivery Ther. [Internet]. 2026 Jul. 15 [cited 2026 Jul. 16];16(7):27-32. Available from: https://www.jddtonline.info/index.php/jddt/article/view/7906

How to Cite

1.
Bamigbola EA, Oraeluno JN, Ekezie AV. Biopharmaceutics and pharmacokinetics of plain and soluble brands of aspirin tablets embedded in food bolus orally administered to human volunteers. J. Drug Delivery Ther. [Internet]. 2026 Jul. 15 [cited 2026 Jul. 16];16(7):27-32. Available from: https://www.jddtonline.info/index.php/jddt/article/view/7906